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The emergence of malarial resistance to most antimalarial drugs is the main factor driving the continued
effort to identify/discover new agents for combating the disease. Moreover, the unacceptably high
mortality rate in severe malaria has led to the consideration of adjuvant therapies. Senna singueana
leaves are traditionally used against malaria and fever. Extracts from the leaves of this plant demon-
strated in vitro and in vivo antioxidant activities, which in turn could reduce the severity of malaria.
Extracts from the root bark of this plant exhibited antiplasmodial activity; however, the leaves are the
more sustainable resource. Thus, S. singueana leaf was selected for in vivo evaluation as a potential
alternative or adjuvant therapy for malaria. Using malaria [Plasmodium berghei ANKA, chloroquine (CQ)
sensitive]-infected Swiss albino mice of both sexes, 70% ethanol extract of S. singueana leaves (alone and
in combination with CQ) was tested for antimalarial activity and adjuvancy potential. The 4-day sup-
pressive test was used to evaluate antimalarial activity. The dose of S. singueana extract administered was
safe to mice and exhibited some parasite suppression effect: extract doses of 200 mg/kg/d, 400 mg/kg/d,
and 800 mg/kg/d caused 34.54%, 44.52%, and 47.32% parasite suppression, respectively. Concurrent
administration of the extract with CQ phosphate at varied dose levels indicated that the percentage of
parasite suppression of this combination was higher than administering CQ alone, but less than the sum
of the effects of the extract and CQ acting separately. In conclusion, the study indicated that 70% ethanol
extract of S. singueana leaf was safe to mice and possessed some parasite suppression effect. Coadmin-
istration of the extract with CQ appeared to boost the overall antimalarial effect, indicating that the
combination may have a net health beneﬁt if used as an adjuvant therapy.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Human malaria is mainly caused by four plasmodium species
(Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale,
and Plasmodium vivax). Recently, a ﬁfth human parasite (Plasmo-
dium knowlesi) has been reported. Of these, P. falciparum is themost
widespread, causes the most severe infections, and is responsible
for nearly all malaria-related deaths.1e4 Malaria remains a major, College of Health Sciences,
e, Ethiopia.
ebrahtom.gebrelibanos@mu.
for Food and Biomolecules,
molecules, National Taiwan Univecause of morbidity andmortality worldwide, with the vast majority
of cases reported in African countries.5 The global spread of
multidrug-resistant malarial parasites has led to an urgent need to
develop new chemotherapeutic agents.6 Furthermore, a signiﬁcant
number of malarial patients progress to severe malaria with organ
dysfunction, which is more common in immunologically naïve in-
dividuals, especially young children.7 The current primary treat-
ment for severe malaria is parenteral quinine or administration of
artemisinin derivatives. Despite improved survival with artemisi-
nin derivatives, mortality rate in severe malarial cases treated with
either artemisinin derivatives or quinine remains unacceptably
high, and therefore, adjuvant therapies (additional therapies that
modify the pathophysiologic processes caused by malaria) are ur-
gently needed.5,7 Accordingly, numerous adjuvant therapies have
been tested and some of those under clinical trials for severersity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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ulants, and agents with antiseizure activity.5
Medicinal plants are the most important sources of new antima-
larial drugs as well as adjuvant therapies for severe malaria. Histori-
cally, plants have provided two major drugs for the treatment of
malaria, namely, quinine from Cinchona species and artemisinin from
Artemisia annua.8,9 Major drugs that are available for infectious dis-
eases, particularly for malaria, have been obtained from plants. In
malaria-endemic regions, people use traditional medicinal plants to
treat malaria and the fever or symptoms associated with this pa-
thology.9 One such medicinal plant is Senna singueana (Del.) Lock
(Syn: Cassia singueana; Fabaceae), which has many medicinal uses
throughout Africa,10 including traditional antimalarial uses. Its leaf
sap is drank to combat malaria in Tanzania11 and a hot decoction of
powdered leaves, taken orally, is indicated for malaria and fever in
Kenya12 and Burkina Faso.11,13 Previous studies have indicated that
methanolic extract of the root bark of the plant exhibited signiﬁcant
antiplasmodial activity against Plasmodium berghei.14 The root bark is
also reported to contain lupeol,10 a triterpene that exhibits a wide
spectrum of biological activity such as antimalarial effects against
chloroquine (CQ)-resistant P. falciparum.15 Although S. singueana has
numerous medicinal uses, research into its pharmacology has been
scarce and is restricted to the root bark. Because of itsmanymedicinal
uses, research into theproperties of its leaves iswarranted, as theyare
a more sustainable source of medicine than the root or stem bark.10
Furthermore, scientiﬁc claims indicate that various extracts of the
leaf possess in vitro and in vivo antioxidant activities16e18. Antioxidant
therapy using the leaf extract of S. singueana is claimed to reduce
malarial severity.7 Taking these considerations into account, the aim
of this work was to evaluate the effectiveness of S. singueana as an
antimalarial agent or as an adjuvant therapy for severe malaria.2. Materials and methods
2.1. Collection of plant material and preparation of extract
Sufﬁcient amounts of S. singueana leaves were collected in
March 2013 from the northwest and central zones of Tigray,
Northern Ethiopia. The plant material was authenticated at the
National Herbarium, Department of Biology, Addis Ababa Univer-
sity (Addis Ababa, Ethiopia). Photographs of S. singueana taken
during collection at the collection site and collected leaves are
shown in Fig. 1. The collected leaves were sorted, dried, powdered,
and then defatted using petroleum ether (HiMedia Laboratories,
Mumbai, India) for 48 hours. The marc was then allowed to dry and
extracted three times by maceration using 70% ethanol with
intermittent agitation. Each maceration was carried out for 72Fig. 1. Photographs of Senna singueana (Del.)hours. The extracts were ﬁltered, collected, concentrated under
reduced pressure using Rotavapor (BIBBY Sterlin Ltd, stuart®, UK),
and dried in a vacuum oven at 35C. The dried extracts were then
transferred into vials and stored for further use.
2.2. Experimental animals and parasite
Swiss albino mice of both sexes (8e12 weeks of age) were ob-
tained from the Pharmacology Animal House of the Department of
Pharmacy, College of Health Sciences (Mekelle University, Mekelle,
Ethiopia). The animals were housed in an air-conditioned room and
were allowed to acclimatize for 1 week before the study. Before and
during the experiment, the animals were provided with standard
animal feed or pellets and clean water ad libitum. P. berghei ANKA
strain (CQ sensitive)-infected donor mice were obtained from the
Faculty of Science, Addis Ababa University (Addis Ababa, Ethiopia).
The parasite was subsequently maintained in the Pharmacology
Laboratory of the Department of Pharmacy, College of Health Sci-
ences, Mekelle University by serial blood passage from one mouse
to another.
2.3. Ethical considerations
The study was performed after obtaining ethical approval from
the Institutional Review Committee of the College of Health Sci-
ences, Mekelle University. All experiments were carried out in
accordance with scientiﬁc procedures. Ethical issues, especially the
handling of experimental animals, were respected.
2.4. Acute oral toxicity test
An acute oral toxicity study was performed according to the
Organization for Economic Cooperation and Development guide-
lines 423,19 but with a slight modiﬁcation in the number of mice
used. The study animals (n ¼ 20 mice) were divided into four
groups of ﬁvemice per cage. The animals were physically active and
their consumption of food and water was normal. Before the
administration of a single dose of the extract, the mice fasted for 2
hours. First, an acute oral toxicity study was performed on ﬁve fe-
male mice (weight, 30e32 g). The mice were given 2000 mg/kg of
the extract dissolved in distilledwater. The test was then performed
on the remaining 15 mice (10 female and 5 male; weight, 23e25 g),
which were divided into three groups of ﬁve each: The ﬁrst group
(5 female mice) was given distilled water, whereas the second (5
female mice) and third (5 male mice) groups were given the
hydroalcoholic leaf extract of S. singueana (5000 mg/kg dissolved in
distilled water). After the oral administration of 0.5 mL of the testLock (Fabaceae) and the collected leaves.
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ously observed during the ﬁrst 30 minutes, periodically observed
during the ﬁrst 24 hours, with particular attention during the ﬁrst 4
hours, and observed daily thereafter. The mice in the control group
received 0.5 mL of distilled water. The animals were observed for 14
days for gross behavioral changes such as loss of appetite, hair
erection, lacrimation, tremors, convulsions, salivation, diarrhea,
mortality, and other signs of toxicity manifestation.19
2.5. Antiplasmodial activity test of extract alone and in
combination with CQ
The commonly used method of a 4-day suppressive test (Peters'
test) was used to evaluate antimalarial activity. Swiss albino mice
were randomly divided into ﬁve groups of ﬁve mice per cage: three
test groups and two control groups (CQwas used as a standard drug
and distilled water as a negative control). Blood was taken from
donor mice with approximately 24% parasitemia and diluted in
physiological saline (2 mL blood was diluted with normal saline to
8mL). Miceweighing 25e30 gwere infected with 0.2mL (z1107
P. berghei-parasitized erythrocytes) diluted blood intraperitoneally.
Test extracts were prepared in three different doses (200 mg/kg,
400 mg/kg, and 800 mg/kg of body weight). CQ phosphate was
prepared at a dose of 25 mg/kg. The total volume of each dose was
0.5 mL. The extract (0.5 mL) or standard drug was administered as a
single dose per day using oral gavages. Treatment was started 2
hours after the infection on Day 0 and was then continued daily for
4 days (i.e., from Day 0 to Day 3). On the 5th day (Day 4), thin blood
smears, on microscopic slides, were obtained from the tail of each
mouse. The blood smears were ﬁxed with methanol and stained
with 10% Giemsa for 15 minutes. The parasitemia level was deter-
mined by counting the number of parasitized erythrocytes from six
random ﬁelds of the microscope. The average percentage of para-
sitemia and suppression were calculated as follows:
% Parasitemia¼ Number of parasitized Red Blood Cells ðRBCÞ
Total number of RBC count
 100% Suppression ¼ ðMean parasitemia of negative controlmean parasitemia of treated miceÞ
Mean parasitemia of negative control
 100
Table 1
Mean percentage of parasitemia in the different treatment groups.
Treatment groups Mean % parasitemia
Distilled water 24.26 ± 0.41
200 mg/kg extract 15.88 ± 3.75
400 mg/kg extract 13.46 ± 2.57
800 mg/kg extract 12.77 ± 1.58
25 mg/kg chloroquine 0.00 ± 0.00
Distilled water served as the negative control, whereas chloroquine was
the positive control.The 4-day suppression test was used to assess the adjuvant
potential of the extract. The antiplasmodial effect of the hydro-
alcoholic leaf extract in combination with CQ phosphate against
P. berghei infection inmicewas determined. Forty Swiss albinomice
were randomly divided into eight groups of ﬁve mice per cage:
three groups received different doses of CQ alone (0.1 mg/kg, 1 mg/
kg, and 10 mg/kg), another three groups received different doses of
CQ (0.1mg/kg,1mg/kg, and 10mg/kg) in combinationwith 500mg/
kg of extract. The seventh group received only 500 mg/kg of the
extract and the eighth group received distilled water as a negative
control. All mice were infected with 0.2 mL of diluted blood. The
remaining steps of the procedure were carried out as stated earlier.
2.6. Data analysis
Data were analyzed using Windows SPSS Version 16 (SPSS Inc.,
Chicago, USA). The results were compared among and withingroups by one-way analysis of variance followed by Tukey's hon-
estly signiﬁcant difference post hoc test. The resultswere considered
signiﬁcant at a value of p < 0.05.3. Results and discussion
3.1. Preparation of plant extract
Traditional medicines are often used in the form of aqueous or
hydroalcohol preparations. S. singueana juice or decoction is used as
the traditional antimalarial remedy.11e13 Ethanol is the solvent of
choice for obtaining classical extracts and ethanol is usually mixed
with water to optimize extraction. Thus, 70% ethanol (ethanol/
water ratio 7:3) was used in this study to prepare the plant extract.
The percentage yield was 19.6%.3.2. Acute toxicity
In general, historical use of a material in traditional medicine is
an indicator that the material is nontoxic.8 However, the activity of
the material still has to be supported with scientiﬁc evidence. In
acute toxicity studies, no mortality or sign of toxicity was observed
in study animals after the oral administration of S. singueana
hydroalcoholic leaf extract even at doses as high as 5000 mg/kg,
indicating that S. singueana leaf can be used as a safe herbal
product. However, while doing the ﬁrst acute toxicity test at a
dose of 2000 mg/kg, a slight reduction in the average weight of
the mice was observed during the initial 14-day observation
period, which could be an indication of possible toxicity. Thus, to
further verify whether the extract actually caused the weight
reduction, the test was repeated while making some modiﬁcations
as follows: (1) the dose was increased to 5000 mg/kg; (2) mice of
both sexes were used; and (3) mice below the age of 8 weeks were
used. The results of this test conﬁrmed that the S. singueana leaf
extract was not the cause of the weight reduction. Thus, the
extract does not have any obvious toxicity even at a single dose as
high as 5000 mg/kg. Supporting reports include the following:
80% methanolic extract of S. singueana leaves was safe for rats andit did not cause mortality at an oral dose of up 4000 mg/kg. In
addition, it was indicated that the use of the extract for thera-
peutic medication may not be a health hazard to humans.20e22 By
contrast, Ruffo et al23 suggested that S. singueana is known to be
toxic and care should be taken while using it medicinally. Thus,
although the existing evidence indicates that S. singueana leaf can
Table 2
Mean percentage of parasitemia in the different treatment groups.
Treatment groups Mean % parasitemia
Distilled water 14.24 ± 0.72
0.1 mg/kg CQ 9.13 ± 0.74
1 mg/kg CQ 8.43 ± 1.37
10 mg/kg CQ 3.51 ± 0.12
500 mg/kg extract 8.16 ± 0.19
0.1 mg/kg CQ þ 500 mg/kg extract 7.66 ± 0.47
1 mg/kg CQ þ 500 mg/kg extract 7.21 ± 0.60
10 mg/kg CQ þ 500 mg/kg extract 2.44 ± 0.06
Distilled water was used as the negative control.
CQ ¼ chloroquine.
Fig. 2. Percentage of parasitemia suppression at different doses (200 mg/kg/d, 400 mg/
kg/d, and 800 mg/kg/d) of Senna singueana leaf extract compared with the negative
control [distilled water (DW)] and the positive control [25 mg/kg/d of chloroquine
phosphate (25 CQ)].
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if long-term use is intended.
3.3. Screening for antimalarial activity and adjuvancy potential
Experimental results are presented as a tabular summary and
include mean percentage of parasitemia for evaluating antimalarial
activity (Table 1), adjuvancy potential testing (Table 2), and the
mean survival time of animals during testing of both antimalarial
activity and adjuvancy potential (Table 3).
3.4. Antimalarial activity of S. singueana leaf extract
The results of this study indicated that S. singueana hydro-
alcoholic leaf extract possesses antiplasmodial activity against
P. berghei in vivo. Compared with the negative control, the extract
reduced the percentage of parasitemia (Table 1); however, none of
the animals survived in any of the doses administered. Extract doses
of 200 mg/kg/d, 400 mg/kg/d, and 800 mg/kg/d caused 34.54%,
44.52%, and 47.32% chemosuppression, respectively (Fig. 2). These
results indicate that the extract exhibited some dose-dependent
activity but dose dependency was not statistically signiﬁcant
(p > 0.05). When compared with the negative control, the chemo-
suppressive effect of S. singueana hydroalcoholic leaf extract was
signiﬁcant (p < 0.05) for doses 400 mg/kg/d. CQ had 100% che-
mosuppression at a dose of 25mg/kg/d. Although the differencewas
not statistically signiﬁcant at 95% conﬁdence interval, better mean
survival timewas observed in the extract-treatedmice than in mice
that received distilled water (Table 3). This may be because the
relatively lower antimalarial activity and low potency of the extract
may not be able to inhibit the growth of the parasite especiallyTable 3
Mean survival time of mice during antimalarial testing and adjuvancy potential in
the different treatment groups.
Treatment groups Mean survival time (d)
Mean survival time of mice during antimalarial testing
GI (distilled water) 7.7 ± 0.43589
GII (200 mg/kg extract) 7.8 ± 0.25495
GIII (400 mg/kg extract) 8.4 ± 0.18708
GIV (800 mg/kg extract) 8.7 ± 0.12247
GV (25 mg/kg CQ) All survived
Mean survival time of mice during testing for adjuvancy potential
Distilled water 9.9 ± 0.24495
0.1 mg/kg CQ 10.3 ± 0.20000
1 mg/kg CQ 11.4 ± 0.50990
10 mg/kg CQ Four survived but one died on Day 12
500 mg/kg extract 11 ± 0.52440
0.1 mg/kg CQ þ 500 mg/kg extract 11.4 ± 0.18708
1 mg/kg CQ þ 500 mg/kg extract 13.00 ± 0.35355
10 mg/kg CQ þ 500 mg/kg extract All survived
In antimalarial testing, distilled water was used as the negative control, whereas
chloroquine was used as the positive control.
CQ ¼ chloroquine.during the late stages (Days 3 and 4) of infection, which is normally
associated with a critically high percentage of parasitemia.24
The study of antiprotozoal compounds from plants has
beneﬁted from the development of bioassay techniques. The 4-day
suppressive test (Peters' test) is the commonly applied method that
uses P. berghei in mice for antimalarial screening,8,9 and determi-
nation of percentage of parasitemia suppression is the most reliable
parameter for evaluating antimalarial efﬁciency. Based on the
measurement results, the in vivo antiplasmodial activity of an
extract can be classiﬁed as moderate, good, and very good if an
extract displays a percentage of parasite suppression 50% at a
dose of 500 mg/kg body weight/d, 250 mg/kg body weight/d, and
100 mg/kg body weight/d, respectively.25,26 According to this
classiﬁcation, the results of this study show that the hydroalcoholic
extract of S. singueana leaf exhibited more or less moderate anti-
plasmodial activity as the percentage of parasite suppression was
less than 50% even at a dose of 800 mg/kg, although it was
incomparable to the standard drug, CQ. This perhaps might be due
to the crude nature of the extract.27 Previous studies reported a
percentage of parasite suppression of 66.51% for the methanolic
extract of the root bark at a dose of 100 mg/kg, which indicates that
the methanolic extract exhibited very good antiplasmodial activity
against P. berghei.14 In comparison, the leaf part, although a rela-
tively sustainable resource, displayed lower antiplasmodial activity
than the root part. However, the study provides evidence to supportFig. 3. Percentage of parasitemia suppression using chloroquine alone and using a
combination of Senna singueana extract and chloroquine. G1 ¼ four groups [distilled
water (DW) and three doses of chloroquine (CQ1e3; 0.1 mg/kg/d, 1 mg/kg/d, and
10 mg/kg/d)]; G2 ¼ four groups [extract (500 mg/kg/d), extract combined with three
doses of chloroquine (CQE1e3; 0.1 þ 500 mg/kg/d), 1 þ 500 mg/kg/d), and
10 þ 500 mg/kg/d)].
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Furthermore, diterpene phytol is reported to be a major constituent
of S. singueana leaves18; phytol in the leaves exhibits antiplasmodial
activity against CQ-sensitive and CQ-resistant strains of
P. falciparum.28,29 Phytol also showed antitrypanosomal activity.30
Thus, among others, the antimalarial activity of S. singueana
leaves might be attributed to the presence of the terpene class of
constituents, which have been implicated in antiplasmodial activ-
ities of many plants.31e33
3.5. Antimalarial activity of the combination of S. singueana extract
and CQ
The effect of the combination of S. singueana extract and CQ
phosphate in all the tested dose levels (Table 2) showed that the
percentage of parasite suppression of the combination was higher
than CQ alone, but less than the sum of the effects of the extract and
CQ acting separately (Fig. 3). These results show that although the
overall net effect of the combination was better than CQ alone,
there existed an interaction between CQ and the extract. Moreover,
while combining the different doses of CQ phosphate solutions
with the extract solution, each combination was changed to sus-
pension, which could indicate the occurrence of at least some
physical interaction. Such an interaction in turn may inﬂuence the
pharmacokinetics of both chloroqhine (CQ) and constituents of the
extract. It is possible to consider a pharmacodynamic inﬂuence but
it may be quite complex to explain. Literature supports the fact that
various plant extracts inﬂuence the pharmacokinetic parameters of
CQ both negatively and positively. For example, it has been reported
that most of the pharmacokinetic parameters of CQwere decreased
and the bioavailability and effectiveness impaired following con-
current administration of CQwith an aqueous extract of Azadirachta
indica leaf,34 ethanol extracts of leaves of Gnetum africana, Heinsia
crinita, Telfairia occidentalis, and Vernonia amygdalina.35e38 By
contrast, grapefruit juice39 and spinach40 were shown to increase
the blood level of CQ. Some extracts even demonstrated synergistic
interaction41, and various studies support the use of plant prepa-
rations as potential adjuvants to CQ therapy.6,42 Despite the
possible extractedrug interaction, coadministration of S. singueana
hydroalcoholic leaf extract with CQ appeared to increase the overall
antimalarial effect. Moreover, a better mean survival time was
observed in the mice that received a combination of extract and CQ
than CQ alone at all tested concentrations (Table 3). A statistically
signiﬁcant mean survival time was seen between a (500 mg/kg
extractþ 1mg/kg CQ)-combination and 1mg/kg CQ alone, whereas
this was not true between a (500 mg/kg extract þ 0.1 mg/kg CQ)-
combination and 0.1 mg/kg CQ alone. All ﬁve mice that received
the (500 mg/kg extract þ 10 mg/kg CQ) combination survived, of
which only four survived after receiving 10 mg/kg CQ alone. The
ﬁfth mouse died on the 12th day. Therefore, it can be suggested that
the extract may boast a net health beneﬁt if used as an adjuvant
therapy to support CQ for the treatment of malaria.
4. Conclusion
In this study, results of acute toxicity and antiplasmodial activity
tests on Swiss albino mice indicated that 70% ethanol extract of
S. singueana leaves was relatively safe to mice and demonstrated
antimalarial activity, which may contribute to its traditional use for
the management of malaria and related symptoms such as fever.
The results also indicated that despite the possible extractedrug
interaction, concurrent use of CQ and S. singueana leaf extract
appeared to increase the overall antimalarial effect, and therefore,
the extract may have a net health beneﬁt if used as an adjuvant
therapy to support CQ for the treatment of malaria.Conﬂicts of interest
All contributing authors declare no conﬂicts of interest.Acknowledgments
The project has been funded from the recurrent budget of Col-
lege of Health Science, Mekelle University (Mekelle, Ethiopia). The
malarial parasite was obtained from the Faculty of Science, Addis
Ababa University (Addis Ababa, Ethiopia). The authors are very
grateful to both institutes.
M.G.H. designed the study, collected the plant material, per-
formed laboratory work, data analysis, data interpretation, and
wrote the paper. G.G.S. participated in the selection and handling of
Plasmodium berghei-infected donor mice. Both G.G.S. and B.S.F.
participated in the study design, laboratorywork, data analysis, and
interpretation. H.D.G. and S.B.T. organized and helped with the
parasite count component of the laboratory work. All authors read,
commented, and approved the ﬁnal manuscript.References
1. World Health Organization. WHO Model Prescribing Information: Drugs Used in
Parasitic Diseases. 2nd ed. Geneva, Switzerland: World Health Organization;
1995.
2. Cox-Singh J, Hiu J, Lucas SB, Divis PC, Zulkarnaen M, Chandran P, et al. Severe
malariada case of fatal Plasmodium knowlesi infection with post-mortem
ﬁndings: a case report. Malar J. 2010;9:10. http://dx.doi.org/10.1186/1475-
2875-9-10.
3. Figtree M, Lee R, Bain L, Kennedy T, Mackertich S, Urban M, et al. Plasmodium
knowlesi in Human, Indonesian Borneo. Emerg Infect Dis. 2010;16:672e674.
4. Sermwittayawong N, Singh B, Nishibuchi M, Sawangjaroen N, Vuddhakul V.
Human Plasmodium knowlesi infection in Ranong province, southwestern
border of Thailand. Malar J. 2012;11:36. http://dx.doi.org/10.1186/1475-2875-
11-36.
5. John CC, Kutamba E, Mugarura K, Opoka RO. Adjunctive therapy for cerebral
malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev
Anti Infect Ther. 2010;8:997e1008.
6. Carraz M, Jossang A, Franetich JF, et al. A plant-derived morphinan as a novel
lead compound active against malaria liver stages. PLoS Med. 2006;3:e513.
7. Ackerman HC, Beaudry SD, Fairhurst RM. Antioxidant therapy: reducing ma-
laria severity? Crit Care Med. 2009;37:758e760.
8. Trease GE, Evans WC. Pharmacognosy. 15th ed. London, UK: Bailliere Tindall;
2002.
9. Mambu L, Grellier P. Antimalarial compounds from traditionally used medici-
nal plants. In: Colegate SM, Molyneux RJ, eds. Bioactive Natural Products:
Detection, Isolation, and Structural Determination. 2nd ed. Boca Raton, FL: CRC;
2008:491e529.
10. Kawanga V, Bosch CH. Senna singueana (Delile) Lock; 2007. http://database.
prota.org/search.htm [accessed 16.02.14].
11. Fowler DG. Traditional Fever Remedies: A List of Zambian Plants; 2006. http://www.
giftsofhealth.org/ritam/news/Traditional_Fever_remedie1.pdf [last accessed
08.12.13].
12. Nanyingi MO, Mbaria JM, Lanyasunya AL, et al. Ethnopharmacological survey of
Samburu district, Kenya. J Ethnobiol Ethnomed. 2008;4:14. http://dx.doi.org/10.
1186/1746-4269-4-14.
13. Nadembega P, Boussim JI, Nikiema JB, Poli F, Antognoni F. Medicinal plants in
Baskoure, Kourittenga Province, Burkina Faso: an ethnobotanical study.
J Ethnopharmacol. 2011;133:378e395.
14. Adzu B, Abbah J, Vongtau H, Gamaniel K. Studies on the use of Cassia singueana
in malaria ethnopharmacy. J Ethnopharmacol. 2003;88:261e267.
15. Srinivasan T, Srivastava GK, Pathak A, et al. Solid-phase synthesis and bio-
evaluation of Lupeol-based libraries as antimalarial agents. Bioorg Med Chem
Lett. 2002;12:2803e2806.
16. Gebrelibanos M, Asres K, Veeresham C. In vitro radical scavenging activity of
the leaf and bark extracts of Senna singueana (Del.) Lock. Ethiop Pharm J.
2007;25:77e84.
17. Madubunyi II, Ode OJ. In vitro and in vivo antioxidant potential of the meth-
anolic extract of Cassia singueana Delile (Fabaceae) Lock leaves. Comp Clin Path.
2012;21:1565e1569.
18. Ibrahim MA, Koorbanally NA, Islam MS. In vitro anti-oxidative activities and
GC-MS analysis of various solvent extracts of Cassia singueana parts. Acta Pol
Pharm. 2013;70:709e719.
19. OECD. OECD Test Guideline 423. Acute Oral ToxicitydAcute Toxic Class Method.
Paris, France: OECD; 2001.
20. Ode OJ, Nwaehujor CO. The haematological effects of chronic toxicity with
Cassia singueana leaf extract in rats. J Pharm Biomed Sci. 2010;8:1e5.
M.G. Hiben et al. / Journal of Traditional and Complementary Medicine 6 (2016) 112e117 11721. Ode OJ. The antiulcer activities of the methanol extract of Cassia singueana
leaves using indomethacin-induced gastric ulcer model in rats. Adv Sci Res.
2011;2:66e69.
22. Ode OJ, Asuzu OV, Oladele GM. The biochemical changes in rats following
chronic toxicity with Cassia singueana leaf extract. J Pharm Biomed Sci. 2011;8:
1e4.
23. Ruffo CK, Birnie A, Tengn€as B. Edible wild plants of Tanzania. RELMA Technical
Handbook Series 27. Nairobi, Kenya: Regional Land Management Unit
(RELMA) and Swedish International Development Cooperation Agency
(SIDA); 2002.
24. Basir R, Chan KL, Yam MF, et al. Antimalarial activity of selected Malaysian
medicinal plants. Phytopharmacology. 2012;3:82e92.
25. Mu~noz V, Sauvain M, Bourdy G, et al. A search for natural bioactive compounds
in Bolivia through a multidisciplinary approach. Part I. Evaluation of the anti-
malarial activity of plants used by the Chacobo Indians. J Ethnopharmacol.
2000;69:127e137.
26. Deharo E, Bourdy G, Quenevo C, Mu~noz V, Ruiz G, Sauvain M. A search for
natural bioactive compounds in Bolivia through a multidisciplinary approach.
Part V. Evaluation of the antimalarial activity of plants used by the Tacana
Indians. J Ethnopharmacol. 2001;77:91e98.
27. Okokon JE, Antia BS, Igboasoiyi AC, Essien EE, Mbagwu HO. Evaluation of
antiplasmodial activity of ethanolic seed extract of Picralima nitida.
J Ethnopharmacol. 2007;111:464e467.
28. K€ohler I, Jenett-Siems K, Kraft C, et al. Herbal remedies traditionally used
against malaria in Ghana: bioassay-guided fractionation ofMicroglossa pyrifolia
(Asteraceae). Z Naturforsch C. 2002;57:1022e1027.
29. Grace MH, Lategan C, Graziose R, Smith PJ, Raskin I, Lila MA. Antiplasmodial
activity of the ethnobotanical plant Cassia ﬁstula. Nat Prod Commun. 2012;7:
1263e1266.
30. Bero J, Beaufay C, Hannaert V, Herent MF, Michels PA, Quetin-Leclercq J.
Antitrypanosomal compounds from the essential oil and extracts of Keetia
leucantha leaves with inhibitor activity on Trypanosoma brucei glyceraldehyde-
3-phosphate dehydrogenase. Phytomedicine. 2013;20:270e274.31. Batista R, Silva Jr AJ, de Oliveira AB. Plant-derived antimalarial agents: new
leads and efﬁcient phytomedicines. Part II. Non-alkaloidal natural products.
Molecules. 2009;14:3037e3072.
32. Ene AC, Atawodi SE, Ameh DA, Ndukwe GI, Kwanashie HO. Bioassay-guided
fractionation and in vivo antiplasmodial effect of fractions of chloroform
extract of Artemisia maciverae Linn. Acta Trop. 2009;112:288e294.
33. Kaur K, Jain M, Kaur T, Jain R. Antimalarials from nature. Bioorg Med Chem.
2009;17:3229e3256.
34. Nwafor SV, Akah PA, Okoli CO, Onyirioha AC, Nworu CS. Interaction between
chloroquine sulphate and aqueous extract of Azadirachta indica A. Juss
(Meliaceae) in rabbits. Acta Pharm. 2003;53:305e311.
35. Eseyin OA, Edoho EJ, Godwin NE, Igboasoiyi AC, Ekpo A. Effects of the leaf
extract of Telfairia occidentalis on the pharmacokinetics of chloroquine in rats.
Int J Biol Chem. 2007;1:256e260.
36. Igboasoiyia C, Eseyin OA, Udoma NF. The effect of ethanolic extract of Vernonia
amygdalina leaves on some pharmacokinetics parameters of chloroquine in
rats. Res J Pharmacol. 2008;2:24e27.
37. Olorunfemi E, Aniekan E, Emmanuel A, Udoh I. Effects of the leaf of Heinsia
crinita on the pharmacokinetics of chloroquine in rats. Int J Biol Pharm Res.
2010;1:88e93.
38. Eseyin O, Ebong A, Ubobre A, Ekarika J, Udo I. Changes in some pharmacoki-
netics parameters of chloroquine by Gnetum africana. Macedon J Med Sci.
2012;5:275e279.
39. Ali BH, Al-Qarawi A, Mousa HM. Effect of grapefruit juice on plasma chloro-
quine kinetics in mice. Clin Exp Pharmacol Physiol. 2002;29:704e706.
40. Mason P. Drugefood interactions (1). Food and medicines. Continuing pro-
fessional development. Pharmaceutical J. 2002;269:571e573.
41. Muregi FW, Ishih A, Miyase T, et al. Antimalarial activity of methanolic extracts
from plants used in Kenyan ethnomedicine and their interactions with chlo-
roquine (CQ) against a CQ-tolerant rodent parasite, in mice. J Ethnopharmacol.
2007;111:190e195.
42. Singh RK. Tinospora cordifolia as an adjuvant drug in the treatment of hyper-
reactivemalarioussplenomegalydcase reports. J VectorBorneDis. 2005;42:36e38.
